Overview
A homolog of ergonovine containing one more CH2 group. (Merck Index, 11th ed)
Indication
For the prevention and control of excessive bleeding following vaginal childbirth
Associated Conditions
- Angina Pectoris, Variant
- Postpartum Haemorrhage (PPH)
- Postpartum uterine subinvolution
- Uterine Atony
- Uterine Hemorrhage
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/03/16 | Phase 4 | Completed | |||
2019/04/05 | Phase 4 | Completed | |||
2018/07/12 | Phase 4 | Completed | |||
2017/10/05 | Early Phase 1 | Withdrawn | |||
2015/04/06 | Phase 4 | Completed | |||
2009/03/10 | Not Applicable | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals NY LLC | 69238-1605 | ORAL | 0.2 mg in 1 1 | 6/12/2025 | |
| Dispensing Solutions, Inc. | 66336-402 | ORAL | 0.2 mg in 1 1 | 9/22/2011 | |
| Rising Pharma Holdings, Inc. | 16571-735 | ORAL | 0.2 mg in 1 1 | 11/24/2021 | |
| Apotheca, Inc. | 12634-179 | ORAL | 0.2 mg in 1 1 | 2/19/2010 | |
| Breckenridge Pharmaceutical, Inc. | 51991-144 | INTRAVENOUS | 0.2 mg in 1 mL | 7/9/2025 | |
| Granules Pharmaceuticals Inc. | 70010-786 | ORAL | 0.2 mg in 1 1 | 7/26/2023 | |
| ATLANTIC BIOLOGICALS CORP. | 17856-3655 | ORAL | 0.2 mg in 1 1 | 1/31/2020 | |
| Pharmacist Pharmaceutical, LLC | 63704-006 | ORAL | 0.2 mg in 1 1 | 5/26/2011 | |
| Novel Laboratories, Inc. | 40032-140 | ORAL | 0.2 mg in 1 1 | 12/22/2017 | |
| Teva Pharmaceuticals USA, Inc. | 0093-3655 | ORAL | 0.2 mg in 1 1 | 7/1/2018 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.